Schwarz Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCHWARZ PHARMA, and what generic and branded alternatives to SCHWARZ PHARMA drugs are available?
SCHWARZ PHARMA has four approved drugs.
Drugs and US Patents for Schwarz Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schwarz Pharma | THEOCLEAR L.A.-130 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 086569-001 | May 27, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Schwarz Pharma | THEOCLEAR L.A.-260 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 086569-002 | May 27, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Schwarz Pharma | AZDONE | aspirin; hydrocodone bitartrate | TABLET;ORAL | 089420-001 | Jan 25, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.